Aier Eye Hospital Group Co (300015) H1 2025 earnings summary

Executive summary

• Achieved revenue of ¥11.51 billion, up 9.12% year-over-year; net profit attributable to shareholders was ¥2.05 billion, up 0.05% year-over-year.

• Outpatient visits reached 9.25 million, up 16.47% year-over-year; surgeries totaled 879,000, up 7.63%.

• Digital transformation and AI initiatives advanced, with new AI diagnostic tools and remote medical services covering over 20 provinces.

• Continued expansion of hospital network, with 355 domestic hospitals and 169 overseas centers as of June 30, 2025.

Financial highlights

• Operating income: ¥11.51 billion, up 9.12% year-over-year.

• Net profit attributable to shareholders: ¥2.05 billion, up 0.05% year-over-year.

• Net profit excluding non-recurring items: ¥2.04 billion, up 14.30% year-over-year.

• Operating cash flow: ¥3.40 billion, up 19.65% year-over-year.

• Gross margin for main business segments ranged from 30.09% to 56.12%.

Outlook and guidance

• Focus on digital ophthalmology, AI integration, and high-quality development.

• Continued investment in R&D, digital transformation, and talent development.

• Plans to further expand service network and enhance patient satisfaction.